Theoretical aspects of autism: biomarkers—a review

References

• Ahloulay, M., Déchaux, M., Hassler, C., Bouby, N. and Bankir, L. 1996. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J. Clin. Invest. 98:2251–2258.
   Google Scholar
• Aldred, S., Moore, K.M., Fitzgerald, M. and Waring, R.H. 2003. Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 33:93–97.
   PubMed Web of Science ®Google Scholar
• Anderson, C. 2010. Careful counting: How many people have an ASD? Available at: www.iancommunity.org/cs/understanding_research/prevalence (March 2, 2010).
   Google Scholar
• Arnold, G.L., Hyman, S.L., Mooney, R.A. and Kirby, R.S. 2003. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J. Autism Dev. Disord. 33:449–454.
   PubMed Web of Science ®Google Scholar
• Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K. and Hackett, G. 2009. Fetal testosterone and autistic traits. Br. J. Psychol. 100:1–22.
   PubMed Web of Science ®Google Scholar
• Axelrod, J. 1974. The pineal gland: a neurochemical transducer. Science. 184:1341–1348.
   PubMed Web of Science ®Google Scholar
• Axt, A. 1996. Autism viewed as a consequence of pineal gland malfunction. Farmakoter. Psychiat. Neuro. 8:112–134.
   Google Scholar
• Bannon, A.W., Decker, M.W., Holladay, M.W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P.S., Bitner, R.S., Diaz, A., Dickenson, A.H., Porsolt, R.D., Williams, M. and Arneric, S.P. 1998. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:77–81.
   PubMed Web of Science ®Google Scholar
• Bauman, M.L. and Kemper, T.L. (Eds.) 1994. Neuroanatomic observations of the brain in autism. In: The Neurobiology of Autism. Baltimore: Johns Hopkins University Press, pp. 119–145.
   Google Scholar
• Bauman, M.L. and Kemper, T.L. 2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23:183–187.
   PubMed Web of Science ®Google Scholar
• Belmonte, M.K., Cook, E.H. Jr, Anderson, G.M., Rubenstein, J.L., Greenough, W.T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L.M., Powell, S.B., Levitt, P.R., Perry, E.K., Jiang, Y.H., DeLorey, T.M. and Tierney, E. 2004. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol. Psychiatry. 9:646–663.
   PubMed Web of Science ®Google Scholar
• Binstock, T. 2001. Intra-monocyte pathogens delineate autism subgroups. Med. Hypotheses. 56:523–531.
   Google Scholar
• Blatt, G.J., Fitzgerald, C.M., Guptill, J.T., Booker, A.B., Kemper, T.L. and Bauman, M.L. 2001. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31:537–543.
   PubMed Web of Science ®Google Scholar
• Blaylock, R.L. and Strunecka, A. 2009. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr. Med. Chem. 16:157–170.
   PubMed Web of Science ®Google Scholar
• Brainard, G.C. 1978. Pineal research: the decade of transformation. J. Neural Transm. Suppl. 3–10.
   Google Scholar
• Buller, K.M. and Day, T.A. 2002. Systemic administration of interleukin-1beta activates select populations of central amygdala afferents. J. Comp. Neurol. 452:288–296.
   Google Scholar
• Burgess, N.K., Sweeten, T.L., McMahon, W.M. and Fujinami, R.S. 2006. Hyperserotoninemia and altered immunity in autism. J. Autism Dev. Disord. 36:697–704.
   Google Scholar
• Carlsson, M.L. 1998. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. J. Neural Transm. 105:525–535.
   PubMed Web of Science ®Google Scholar
• Cass, H., Gringras, P., March, J., McKendrick, I., O’Hare, A.E., Owen, L. and Pollin, C. 2008. Absence of urinary opioid peptides in children with autism. Arch. Dis. Child. 93:745–750.
   PubMed Web of Science ®Google Scholar
• Cazzullo, A.G., Musetti, M.C., Musetti, L., Bajo, S., Sacerdote, P. and Panerai, A. 1999. Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. Eur. Neuropsychopharmacol. 9:361–366.
   PubMed Web of Science ®Google Scholar
• Chauhan, A. and Chauhan, V. 2006. Oxidative stress in autism. Pathophysiology. 13:171–181.
   PubMedGoogle Scholar
• Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R. and Greenberg, M.E. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 302:885–889.
   PubMed Web of Science ®Google Scholar
• Cheng, L., Ge, Q., Xiao, P., Sun, B., Ke, X., Bai, Y. and Lu, Z. 2009. Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. Int. J. Mol. Sci. 10:2487–2500.
   PubMed Web of Science ®Google Scholar
• Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J. and Chugani, H.T. 1999. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45:287–295.
   PubMed Web of Science ®Google Scholar
• Connolly, A.M., Chez, M., Streif, E.M., Keeling, R.M., Golumbek, P.T., Kwon, J.M., Riviello, J.J., Robinson, R.G., Neuman, R.J. and Deuel, R.M. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry. 59:354–363.
   PubMed Web of Science ®Google Scholar
• Corbett, B.A., Mendoza, S., Abdullah, M., Wegelin, J.A. and Levine, S. 2006. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology. 31:59–68.
   PubMed Web of Science ®Google Scholar
• Corbett, B.A., Mendoza, S., Wegelin, J.A., Carmean, V. and Levine, S. 2008. Variable cortisol circadian rhythms in children with autism and anticipatory stress. J. Psychiatry Neurosci. 33:227–234.
   PubMed Web of Science ®Google Scholar
• Curin, J.M., Terzic, J., Petkovic, Z.B., Zekan, L., Terzic, I.M. and Susnjara, I.M. 2003. Lower cortisol and higher ACTH levels in individuals with autism. J. Autism Dev. Disord. 33:443–448.
   PubMed Web of Science ®Google Scholar
• Davis, M., Rainnie, D. and Cassell, M. 1994. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 17:208–214.
   PubMed Web of Science ®Google Scholar
• DeLorey, T.M., Handforth, A., Anagnostaras, S.G., Homanics, G.E., Minassian, B.A., Asatourian, A., Fanselow, M.S., Delgado-Escueta, A., Ellison, G.D. and Olsen, R.W. 1998. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18:8505–8514.
   PubMed Web of Science ®Google Scholar
• DeMyer, M.K., Hingtgen, J.N. and Jackson, R.K. 1981. Infantile autism reviewed: a decade of research. Schizophr. Bull. 7:388–451.
   PubMed Web of Science ®Google Scholar
• Denney, D.R., Frei, B.W. and Gaffney, G.R. 1996. Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26:87–97.
   Google Scholar
• Elchaar, G.M., Maisch, N.M., Augusto, L.M. and Wehring, H.J. 2006. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Ann. Pharmacother. 40:1086–1095.
   PubMed Web of Science ®Google Scholar
• Evans, C., Dunstan, R.H., Rothkirch, T., Roberts, T.K., Reichelt, K.L., Cosford, R., Deed, G., Ellis, L.B. and Sparkes, D.L. 2008. Altered amino acid excretion in children with autism. Nutr. Neurosci. 11:9–17.
   PubMed Web of Science ®Google Scholar
• Feldman, H.M., Kolmen, B.K. and Gonzaga, A.M. 1999. Naltrexone and communication skills in young children with autism. J. Am. Acad. Child Adolesc. Psychiatry. 38:587–593.
   PubMed Web of Science ®Google Scholar
• Filipek, P.A., Juranek, J., Nguyen, M.T., Cummings, C. and Gargus, J.J. 2004. Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34:615–623.
   PubMed Web of Science ®Google Scholar
• Fuchs, D., Weiss, G. and Wachter, H. 1993. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int. Arch. Allergy Immunol. 101:1–6.
   PubMed Web of Science ®Google Scholar
• Galli-Carminati, G., Deriaz, N. and Bertschy, G. 2009. Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study. Swiss Med. Wkly. 139:293–296.
   PubMed Web of Science ®Google Scholar
• Geier, D.A. and Geier, M.R. 2006a. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox. Res. 10:57–64.
   PubMed Web of Science ®Google Scholar
• Geier, D.A. and Geier, M.R. 2006b. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 66:182–188.
   PubMed Web of Science ®Google Scholar
• Geier, D.A., Kern, J.K., Garver, C.R., Adams, J.B., Audhya, T., Nataf, R. and Geier, M.R. 2009. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280:101–108.
   PubMed Web of Science ®Google Scholar
• Giannotti, F., Cortesi, F., Cerquiglini, A. and Bernabei, P. 2006. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J. Autism Dev. Disord. 36:741–752.
   PubMed Web of Science ®Google Scholar
• Gillberg, C. 1995. Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev. Med. Child Neurol. 37:239–245.
   PubMedGoogle Scholar
• Glickman, G. 2010. Circadian rhythms and sleep in children with autism. Neurosci. Biobehav. Rev. 34:755–768.
   PubMed Web of Science ®Google Scholar
• Grigorenko, E.L., Han, S.S., Yrigollen, C.M., Leng, L., Mizue, Y., Anderson, G.M., Mulder, E.J., de Bildt, A., Minderaa, R.B., Volkmar, F.R., Chang, J.T. and Bucala, R. 2008. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics. 122:e438–e445.
   Google Scholar
• Hardan, A.Y. and Handen, B.L. 2002. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J. Child Adolesc. Psychopharmacol. 12:237–241.
   PubMed Web of Science ®Google Scholar
• Hare, D.J., Jones, S. and Evershed, K. 2006. A comparative study of circadian rhythm functioning and sleep in people with Asperger syndrome. Autism. 10:565–575.
   Google Scholar
• Hashimoto, K., Iwata, Y., Nakamura, K., Tsujii, M., Tsuchiya, K.J., Sekine, Y., Suzuki, K., Minabe, Y., Takei, N., Iyo, M. and Mori, N. 2006. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry. 30:1529–1531.
   PubMed Web of Science ®Google Scholar
• Hohmann, C.F. and Berger-Sweeney, J. 1998. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect. Dev. Neurobiol. 5:401–425.
   Google Scholar
• Hollander, E., DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cartwright, C., DeCaria, C.M., Kwon, J., Cunningham-Rundles, C., Chapman, F. and Zabriskie, J.B. 1999. B lymphocyte antigen D8/17 and repetitive behaviors in autism. Am. J. Psychiatry. 156:317–320.
   PubMed Web of Science ®Google Scholar
• Holmes, C., El-Okl, M., Williams, A.L., Cunningham, C., Wilcockson, D. and Perry, V.H. 2003. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatr. 74:788–789.
   PubMed Web of Science ®Google Scholar
• Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C. and Tildon, J.T. 1999. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135:559–563.
   PubMed Web of Science ®Google Scholar
• Horvath, K. and Perman, J.A. 2002. Autistic disorder and gastrointestinal disease. Curr. Opin. Pediatr. 14:583–587.
   PubMed Web of Science ®Google Scholar
• Hoshino, Y., Kumashiro, H., Yashima, Y., Kaneko, M., Numata, Y., Oshima, N. and Watanabe, A. 1980. Plasma cyclic AMP level in psychiatric diseases of childhood. Folia Psychiatr. Neurol. Jpn. 34:9–16.
   PubMedGoogle Scholar
• Hoshino, Y., Kumashiro, H., Yashima, Y., Tachibana, R., Watanabe, M. and Furukawa, H. 1982. Early symptoms of autistic children and its diagnostic significance. Folia Psychiatr. Neurol. Jpn. 36:367–374.
   PubMedGoogle Scholar
• Hunter, L.C., O’Hare, A., Herron, W.J., Fisher, L.A. and Jones, G.E. 2003. Opioid peptides and dipeptidyl peptidase in autism. Dev. Med. Child Neurol. 45:121–128.
   PubMed Web of Science ®Google Scholar
• Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M. and Bourgeron, T. Paris Autism Research International Sibpair (PARIS) Study. 2002. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry. 7:302–310.
   PubMed Web of Science ®Google Scholar
• James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W. and Neubrander, J.A. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:1611–1617.
   PubMed Web of Science ®Google Scholar
• Jepson B. (Ed.) 2007a. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 176–180.
   Google Scholar
• Jepson B. (Ed.) 2007b. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 225.
   Google Scholar
• Jepson B. (Ed.) 2007c. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 226.
   Google Scholar
• Jepson B. (Ed.) 2007d. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 227.
   Google Scholar
• Jyonouchi, H., Sun, S. and Le, H. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170–179.
   PubMed Web of Science ®Google Scholar
• Kaplan, D.R. and Miller, F.D. 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:381–391.
   PubMed Web of Science ®Google Scholar
• Kaufman, S. 1986. The metabolic role of tetrahydrobiopterin. In: Chemistry and Biology of Pteridines (Cooper, B.A. and Whitehead, V.A., Eds.), Berlin: Walter de Gruyter, pp. 185–200.
   Google Scholar
• Kelley, D.J., Bhattacharyya, A., Lahvis, G.P., Yin, J.C., Malter, J. and Davidson, R.J. 2008. The cyclic AMP phenotype of Fragile X and autism. Neurosci. Biobehav. Rev. 32:1533–1543.
   PubMed Web of Science ®Google Scholar
• Kelley, R.I. and Hennekam, R.C. 2000. Smith-Lemli-Opitz syndrome. In: The Metabolic and Molecular Basics of Inherited Disease, 8th Edit. (Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D., Eds.), New York: McGraw-Hill, pp. 6183–6201.
   Google Scholar
• Kemper, T.L. and Bauman, M. 1998. Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 57:645–652.
   PubMed Web of Science ®Google Scholar
• Kitay, J.L. and Altschule, M.P. (Eds.) 1954. The Pineal Gland. Cambridge, MA: Harvard Univ. Press, pp. 72–74.
   Google Scholar
• Klauck, S.M., Poustka, F., Benner, A., Lesch, K.P. and Poustka, A. 1997. Serotonin transporter (5-HTT) gene variants associated with autism? Hum. Mol. Genet. 6:2233–2238.
   PubMed Web of Science ®Google Scholar
• Knickmeyer, R., Baron-Cohen, S., Raggatt, P. and Taylor, K. 2005. Foetal testosterone, social relationships, and restricted interests in children. J. Child Psychol. Psychiatry. 46:198–210.
   PubMed Web of Science ®Google Scholar
• Köhler, M., Assmann, B., Bräutigam, C., Storm, W., Marie, S., Vincent, M.F., Van den Berghe, G., Simmonds, H.A. and Hoffmann, G.F. 1999. Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features. Eur. J. Paediatr. Neurol. 3:3–6.
   Google Scholar
• Kolvin, I. 1971. Studies in the childhood psychoses. I. Diagnostic criteria and classification. Br. J. Psychiatry. 118:381–384.
   PubMed Web of Science ®Google Scholar
• Koukkari, W.L. and Sothern, R.B. (Eds.) 2006. Introducing Biological Rhythms. New York: Springer, pp. 1–18.
   Google Scholar
• Kulman, G., Lissoni, P., Rovelli, F., Roselli, M.G., Brivio, F. and Sequeri, P. 2000. Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinol. Lett. 21:31–34.
   PubMed Web of Science ®Google Scholar
• Kunkel, S.L., Ward, P.A., Caporale, L.H. and Vogel, C.W. 1985. The Complement System In: Immunology III (Bellanti, J. A., Ed.). Philadelphia: W.B. Saunders Co., pp. 106–116.
   Google Scholar
• Laurie, D.J., Wisden, W. and Seeburg, P.H. 1992. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J. Neurosci. 12:4151–4172.
   PubMed Web of Science ®Google Scholar
• Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.C. and Launay, J.M. 1999. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol. Psychiatry. 45:158–163.
   PubMed Web of Science ®Google Scholar
• Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iversen, P., Bauman, M. and Perry, E. 2002. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain. 125:1483–1495.
   PubMed Web of Science ®Google Scholar
• Lerner, A.B., Case, J.D., Takahashi, Y., Lee, T.H. and Mori, W. 1958. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 80:2587.
   Web of Science ®Google Scholar
• Lerner, A.B., Case, J.D. and Takahashi, Y. 1960. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 235:1992–1997.
   PubMed Web of Science ®Google Scholar
• Lord, C., Rutter, M. and Le Couteur, A. 1994. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24:659–685.
   PubMed Web of Science ®Google Scholar
• Luboshitzky, R., Wagner, O., Lavi, S., Herer, P. and Lavie, P. 1996. Decreased nocturnal melatonin secretion in patients with Klinefelter’s syndrome. Clin. Endocrinol. (Oxf). 45:749–754.
   PubMed Web of Science ®Google Scholar
• Luboshitzky, R., Wagner, O., Lavi, S., Herer, P. and Lavie, P. 1997. Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment. Clin. Endocrinol. (Oxf). 47:463–469.
   Google Scholar
• Lucki, I. 1998. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry. 44:151–162.
   PubMed Web of Science ®Google Scholar
• Malhotra, S., Sawhney, G. and Pandhi, P. 2004. The therapeutic potential of melatonin: a review of the science. MedGenMed. 6:46.
   PubMedGoogle Scholar
• Malow, B.A., Marzec, M.L., McGrew, S.G., Wang, L., Henderson, L.M. and Stone, W.L. 2006. Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 29:1563–1571.
   PubMed Web of Science ®Google Scholar
• Marinovic-Curin, J., Marinovic-Terzic, I., Bujas-Petkovic, Z., Zekan, L., Skrabic, V., Dogas, Z. and Terzic, J. 2008. Slower cortisol response during ACTH stimulation test in autistic children. Eur. Child Adolesc. Psychiatry. 17:39–43.
   Google Scholar
• Martineau, J., Barthélémy, C., Jouve, J., Muh, J.P. and Lelord, G. 1992. Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Dev. Med. Child Neurol. 34:593–603.
   PubMed Web of Science ®Google Scholar
• Martin-Ruiz, C.M., Lee, M., Perry, R.H., Baumann, M., Court, J.A. and Perry, E.K. 2004. Molecular analysis of nicotinic receptor expression in autism. Brain Res. Mol. Brain Res. 123:81–90.
   PubMedGoogle Scholar
• Megson, M.N. 2000. Is autism a G-alpha protein defect reversible with natural vitamin A? Med. Hypotheses. 54:979–983.
   PubMedGoogle Scholar
• Mehl-Madrona, L. 2000. Autism: An overview. www.healing-arts.org/children/autism-overview.htm.
   Google Scholar
• Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I.C., Delorme, R., Chabane, N., Mouren-Simeoni, M.C., Fauchereau, F., Durand, C.M., Chevalier, F., Drouot, X., Collet, C., Launay, J.M., Leboyer, M., Gillberg, C. and Bourgeron, T. 2008. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry. 13:90–98.
   PubMed Web of Science ®Google Scholar
• Messahel, S., Pheasant, A.E., Pall, H., Ahmed-Choudhury, J., Sungum-Paliwal, R.S. and Vostanis, P. 1998. Urinary levels of neopterin and biopterin in autism. Neurosci. Lett. 241:17–20.
   Google Scholar
• Miyashiro, K. and Eberwine, J. 2004. Fragile X syndrome: (What’s) lost in translation? Proc. Natl. Acad. Sci. U.S.A. 101:17329–17330.
   Google Scholar
• Moreno, H., Borjas, L., Arrieta, A., Sáez, L., Prassad, A., Estévez, J. and Bonilla, E. 1992. [Clinical heterogeneity of the autistic syndrome: a study of 60 families]. Invest. Clin. 33:13–31.
   Google Scholar
• Mössner, R. and Lesch, K.P. 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12:249–271.
   PubMed Web of Science ®Google Scholar
• Muhle, R., Trentacoste, S.V. and Rapin, I. 2004. The genetics of autism. Pediatrics. 113:e472–e486.
   PubMed Web of Science ®Google Scholar
• Nataf, R., Skorupka, C., Amet, L., Lam, A., Springbett, A. and Lathe, R. 2006. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol. Appl. Pharmacol. 214:99–108.
   PubMed Web of Science ®Google Scholar
• Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., Jelliffe, L.L., Hansen, R.L. and Phillips, T.M. 2001. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49:597–606.
   PubMed Web of Science ®Google Scholar
• Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J. and Lerner, Y. 1995. Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J. Autism Dev. Disord. 25:641–654.
   PubMed Web of Science ®Google Scholar
• Norman, A.W. and Litwach, G. (Eds.) 1987. Hormones. New York: Academic Press, Inc., pp. 711.
   Google Scholar
• Ornitz, E.M., Ritvo, E.R. and Walter, R.D. 1965. Dreaming sleep in autistic and schizophrenic children. Am. J. Psychiatry. 122:419–424.
   Google Scholar
• Ornitz, E.M. 1973. Childhood autism. A review of the clinical and experimental literature. Calif. Med. 118:21–47.
   PubMedGoogle Scholar
• Panksepp, J. 1979. A neurochemical theory of autism. Trends Neurosci. 2:174–177.
   Web of Science ®Google Scholar
• Pennell, P.B., Burdette, D.E., Ross, D.A., Henry, T.R., Albin, R.L., Sackellares, J.C. and Frey, K.A. 1999. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40:38–46.
   Google Scholar
• Perry, E.K., Lee, M.L., Martin-Ruiz, C.M., Court, J.A., Volsen, S.G., Merrit, J., Folly, E., Iversen, P.E., Bauman, M.L., Perry, R.H. and Wenk, G.L. 2001. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 158:1058–1066.
   PubMed Web of Science ®Google Scholar
• Plioplys, A.V., Greaves, A., Kazemi, K. and Silverman, E. 1994. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology. 29:12–16.
   Google Scholar
• Polleux, F. and Lauder, J.M. 2004. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 10:303–317.
   PubMedGoogle Scholar
• Posey, D.J., Stigler, K.A., Erickson, C.A. and McDougle, C.J. 2008. Antipsychotics in the treatment of autism. J. Clin. Invest. 118:6–14.
   PubMed Web of Science ®Google Scholar
• Ratajczak, H.V. 2010. Theoretical aspects.of autism: Causes – A review. J. Immunotoxicol. (submitted for publication).
   Google Scholar
• Reichelt, K.L. and Liu, Y. 1997. Presentation at Defeat Autism Now! Meeting, San Diego, CA. Sept 19–21.
   Google Scholar
• Reichelt, K.L. and Knivsberg, A.M. 2003. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr. Neurosci. 6:19–28.
   PubMed Web of Science ®Google Scholar
• Reiter, R. J., and Robinson, J. (Eds.) 1995a. Melatonin. New York: Bantam Books, pp. 22–23.
   Google Scholar
• Reiter, R. J., and Robinson, J. (Eds.) 1995b. Melatonin. New York: Bantam Books, p. 3.
   Google Scholar
• Reiter, R. J., and Robinson, J. (Eds.) 1995c. Melatonin. New York: Bantam Books, pp. 3–12.
   Google Scholar
• Reiter, R.J., Tan, D.X. and Fuentes-Broto, L. 2010. Melatonin: a multitasking molecule. Prog. Brain Res. 181:127–151.
   PubMed Web of Science ®Google Scholar
• Renzoni, E., Beltrami, V., Sestini, P., Pompella, A., Menchetti, G. and Zappella, M. 1995. Brief report: allergological evaluation of children with autism. J. Autism Dev. Disord. 25:327–333.
   Google Scholar
• Riddle, M.A., Bernstein, G.A., Cook, E.H., Leonard, H.L., March, J.S. and Swanson, J.M. 1999. Anxiolytics, adrenergic agents, and naltrexone. J. Am. Acad. Child Adolesc. Psychiatry. 38:546–556.
   Google Scholar
• Rolf, L.H., Haarmann, F.Y., Grotemeyer, K.H. and Kehrer, H. 1993. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr. Scand. 87:312–316.
   PubMed Web of Science ®Google Scholar
• Rubenstein, J.L. and Merzenich, M.M. 2003. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2:255–267.
   PubMed Web of Science ®Google Scholar
• Sabbagh, M.N., Reid, R.T., Corey-Bloom, J., Rao, T.S., Hansen, L.A., Alford, M., Masliah, E., Adem, A., Lloyd, G.K. and Thal, L.J. 1998. Correlation of nicotinic binding with neurochemical markers in Alzheimer’s disease. J. Neural Transm. 105:709–717.
   PubMed Web of Science ®Google Scholar
• Sanchez de la Pena, S. 1993. The feed-sideward of cephalo-adrenal immune interactions. Chronobiologia 20:1–52.
   PubMedGoogle Scholar
• Selmaoui, B. and Touitou, Y. 2003. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci. 73:3339–3349.
   PubMed Web of Science ®Google Scholar
• Serajee, F.J., Zhong, H., Nabi, R. and Huq, A.H. 2003. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J. Med. Genet. 40:e42.
   PubMedGoogle Scholar
• Shanahan, M.R., Venturini, A.J., Daiss, J.L. and Friedman, A.E. 2000. Peptide diagnostic markers for human disorders. European Patent Application. Ep 0 969 015 A2. 05 Jan.
   Google Scholar
• Shattock, P. and Whiteley, P. 2002. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin. Ther. Targets. 6:175–183.
   PubMedGoogle Scholar
• Singh, V.K., Warren, R.P., Odell, J.D. and Cole, P. 1991. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 61:448–455.
   PubMedGoogle Scholar
• Singh, V.K., Warren, R.P., Odell, J.D., Warren, W.L. and Cole, P. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7:97–103.
   PubMed Web of Science ®Google Scholar
• Singh, V.K. 1996. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 66:143–145.
   PubMed Web of Science ®Google Scholar
• Singh, V.K., Warren, R., Averett, R. and Ghaziuddin, M. 1997. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17:88–90.
   PubMed Web of Science ®Google Scholar
• Slauson, D.O., Walker, C., Kristensen, F., Wang, Y. and de Weck, A.L. 1984. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell. Immunol. 84:240–252.
   PubMedGoogle Scholar
• Stefulj, J., Cicin-Sain, L., Schauenstein, K. and Jernej, B. 2001. Serotonin and immune response: effect of the amine on in vitro proliferation of rat lymphocytes. Neuroimmunomodulation. 9:103–108.
   PubMed Web of Science ®Google Scholar
• Stubbs, E.G. and Crawford, M.L. 1977. Depressed lymphocyte responsiveness in autistic children. J. Autism Child. Schizophr. 7:49–55.
   PubMedGoogle Scholar
• Sweeten, T.L., Posey, D.J. and McDougle, C.J. 2003. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry. 160:1691–1693.
   PubMed Web of Science ®Google Scholar
• Tierney, E., Nwokoro, N.A., Porter, F.D., Freund, L.S., Ghuman, J.K. and Kelley, R.I. 2001. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 98:191–200.
   PubMed Web of Science ®Google Scholar
• Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S. and Salen, G. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330:107–113.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., Anderson, G.M., McBride, P.A., Hertzig, M.E., Snow, M.E., Hall, L.M., Ferrari, P. and Cohen, D.J. 1995. Plasma androgens in autism. J. Autism Dev. Disord. 25:295–304.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., Anderson, G.M., McBride, P.A., Hertzig, M.E., Snow, M.E., Hall, L.M., Thompson, S.M., Ferrari, P. and Cohen, D.J. 1997. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J. Child Psychol. Psychiatry. 38:705–715.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., Antoine, C., Cohen, D.J., Gauvain-Piquard, A., Carlier, M., Roubertoux, P. and Ferrari, P. 1999. [Study of the relationships between self-injurious behavior and pain reactivity in infantile autism]. Encephale. 25:122–134.
   Google Scholar
• Tordjman, S., Anderson, G.M., Pichard, N., Charbuy, H. and Touitou, Y. 2005. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol. Psychiatry. 57:134–138.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., Anderson, G.M., Botbol, M., Brailly-Tabard, S., Perez-Diaz, F., Graignic, R., Carlier, M., Schmit, G., Rolland, A.C., Bonnot, O., Trabado, S., Roubertoux, P. and Bronsard, G. 2009. Pain reactivity and plasma β-endorphin in children and adolescents with autistic disorder. PLoS ONE 4(8):e5289, doi:10.1371/journal.pone.0005289.
   Google Scholar
• Vancassel, S., Durand, G., Barthélémy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andrès, C. and Chalon, S. 2001. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 65:1–7.
   PubMed Web of Science ®Google Scholar
• Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W. and Pardo, C.A. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:67–81.
   PubMed Web of Science ®Google Scholar
• Vojdani, A., Bazargan, M., Vojdani, E., Samadi, J., Nourian, A.A., Eghbalieh, N. and Cooper, E.L. 2004a. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin. Diagn. Lab. Immunol. 11:515–524.
   PubMedGoogle Scholar
• Vojdani, A., O’Bryan, T., Green, J.A., Mccandless, J., Woeller, K.N., Vojdani, E., Nourian, A.A. and Cooper, E.L. 2004b. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr. Neurosci. 7:151–161.
   PubMed Web of Science ®Google Scholar
• Volkmar, F.R., Lord, C., Bailey, A., Schultz, R.T. and Klin, A. 2004. Autism and pervasive developmental disorders. J. Child Psychol. Psychiatry 45:135–170.
   PubMed Web of Science ®Google Scholar
• Volkmar, F. R., and Klin, A. 2005. Issues in the classification of autism and related conditions In: Handbook of Autism and Pervasive Developmental Disorders, 3rd Edition. (Volkmar, F.R., Paul, R., Klin, A., Cohen, D., Eds.), Hoboken, NJ: John Wiley & Sons, Inc., pp. 5–14.
   Google Scholar
• Wakefield, A.J., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E. and Walker-Smith, J.A. 1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–641.
   PubMed Web of Science ®Google Scholar
• Ward, N.L. and Hagg, T. 2000. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp. Neurol. 162:297–310.
   PubMed Web of Science ®Google Scholar
• Waring, R. H., Ngong, J. M., Klovarza, L., Green, S., and Sharp, H. 1997. Biochemical parameters in autistic children. Dev. Brain Dysfunc. 10:40–43.
   Google Scholar
• Waring, R. H., and Klovrza, L. V. 2000. Sulfur metabolism in autism. J. Nutr. Environ. Med. 10:25–32.
   Google Scholar
• Warren, R.P., Margaretten, N.C., Pace, N.C. and Foster, A. 1986. Immune abnormalities in patients with autism. J. Autism Dev. Disord. 16:189–197.
   PubMed Web of Science ®Google Scholar
• Warren, R.P., Foster, A. and Margaretten, N.C. 1987. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26:333–335.
   PubMed Web of Science ®Google Scholar
• Warren, R.P., Yonk, L.J., Burger, R.A., Cole, P., Odell, J.D., Warren, W.L., White, E. and Singh, V.K. 1990. Deficiency of suppressor-inducer (CD4+CD45RA+) T-cells in autism. Immunol. Invest. 19:245–251.
   PubMed Web of Science ®Google Scholar
• Warren, R.P., Singh, V.K., Cole, P., Odell, J.D., Pingree, C.B., Warren, W.L. and White, E. 1991. Increased frequency of the null allele at the complement C4b locus in autism. Clin. Exp. Immunol. 83:438–440.
   Google Scholar
• Warren, R.P., Burger, R.A., Odell, D., Torres, A.R. and Warren, W.L. 1994. Decreased plasma concentrations of the C4B complement protein in autism. Arch. Pediatr. Adolesc. Med. 148:180–183.
   PubMedGoogle Scholar
• Warren, R.P., Yonk, J., Burger, R.W., Odell, D. and Warren, W.L. 1995. DR-positive T-cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31:53–57.
   PubMed Web of Science ®Google Scholar
• Warren, R.P., Singh, V.K., Averett, R.E., Odell, J.D., Maciulis, A., Burger, R.A., Daniels, W.W. and Warren, W.L. 1996. Immunogenetic studies in autism and related disorders. Mol. Chem. Neuropathol. 28:77–81.
   Google Scholar
• Warren, R.P., Odell, J.D., Warren, W.L., Burger, R.A., Maciulis, A., Daniels, W.W. and Torres, A.R. 1997. Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J. Autism Dev. Disord. 27:187–192.
   PubMed Web of Science ®Google Scholar
• Weizman, A., Weizman, R., Szekely, G.A., Wijsenbeek, H. and Livni, E. 1982. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiatry. 139:1462–1465.
   PubMed Web of Science ®Google Scholar
• Werner, E.R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G. and Wachter, H. 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem. J. 262:861–866.
   PubMed Web of Science ®Google Scholar
• Whitaker-Azmitia, P.M. 2001. Serotonin and brain development: Role in human developmental diseases. Brain Res. Bull. 56:479–485.
   PubMed Web of Science ®Google Scholar
• Wikipedia. 2010. Available at http://en.wikipedia.org/’wiki/Interior_olivary_nucleus.
   Google Scholar
• Willemsen-Swinkels, S.H., Buitelaar, J.K., Nijhof, G.J. and van England, H. 1995. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Arch. Gen. Psychiatry 52:766–773.
   PubMed Web of Science ®Google Scholar
• Wing, L. 2005. Problems of categorical classification systems. In: Handbook of Autism and Pervasive Developmental Disorders. Volume 1. 3rd Ed. (Volkmar, F. R., Paul, R., Klin, A., and Cohen, D., Eds.) Hoboken, NJ: Wiley, pp. 583–605.
   Google Scholar
• Wirojanan, J., Jacquemont, S., Diaz, R., Bacalman, S., Anders, T.F., Hagerman, R.J. and Goodlin-Jones, B.L. 2009. The efficacy of melatonin for sleep problems in children with autism, Fragile X syndrome, or autism and Fragile X syndrome. J. Clin. Sleep Med. 5:145–150.
   PubMed Web of Science ®Google Scholar
• Yonk, L.J., Warren, R.P., Burger, R.A., Cole, P., Odell, J.D., Warren, W.L., White, E. and Singh, V.K. 1990. CD4+ helper T-cell depression in autism. Immunol. Lett. 25:341–345.
   PubMed Web of Science ®Google Scholar
• Young, M.R. and Matthews, J.P. 1995. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 84:148–152.
   PubMedGoogle Scholar